Description
Repeats of four common antibiotics would no longer be funded via the PBS under a new plan to tackle antibiotic resistance.
The PBAC proposal, released last week, recommended banning subsidies for repeat scripts of cephalexin, roxithromycin, amoxycillin and amoxycillin-clavulanic acid.
Subject
Antimicrobial resistance
| Period | 9 Oct 2019 |
|---|
Media contributions
1Media contributions
Title Plan to curb repeats of four common antibiotics Degree of recognition National Media name/outlet Australian Doctor News Media type Web Country/Territory Australia Date 9/10/19 Description Repeats of four common antibiotics would no longer be funded via the PBS under a new plan to tackle antibiotic resistance. The PBAC proposal, released last week, recommended banning subsidies for repeat scripts of cephalexin, roxithromycin, amoxycillin and amoxycillin-clavulanic acid.
The move was aimed at aligning public subsidies for antibiotics with recommended lengths of treatment as set out in Therapeutic Guidelines and “would support antimicrobial stewardship and quality use of medicine”, the committee said.Producer/Author Antony Scholefield URL https://www.ausdoc.com.au/news/plan-curb-repeats-four-common-antibiotics?mkt_tok=eyJpIjoiTXpnNE56Y3paak01TmpRMSIsInQiOiJMUGtaM0gxdnFvcWsrRzQ1Rk9FeG9nWm84NXErMURWVXp6Rm05UldcL1lqYTBCd1wvUDlTZlRUQkkzTXlSS3JWeFVmKzdMclM1bVRITUlYQ25Nd0RqQUhyaWVIXC9jNkorMDdBZHIxellGNVpTXC9XZG5lR0U5XC9BVDJzOEpWSnhjaGRNIn0%3D Persons Mark Morgan